|
|
Transcript: FDA WARNS ABOUT PRODUCTS CONTAINING GAMMA BUTYROLACTONE OR GBL AND ASKS COMPANIES TO ISSUE A RECALL
- Article from:
- Regulatory Intelligence Data
- Article date:
- January 21, 1999
- Author:
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
00-00-0000
The Food and Drug Administration is alerting consumers not to purchase
or consume products, some of which are labeled as dietary supplements,
that contain gamma butyrolactone (abbreviated as GBL). FDA has also
asked
the companies that manufacture these products to voluntarily recall
them.
The agency has received reports of serious health problems -- some
that
are potentially life-threatening -- associated with the use of these
products.
Although labeled as dietary supplements, these products are illegally
marketed
unapproved new drugs. Products containing GBL are marketed under various
brand names including Renewtrient, Revivarant or Revivarant G, Blue
Nitro
or Blue ...